文献速递免疫规划

减强度预处理淋巴细胞清除异基因造血干细胞移植后第一年季节性灭活流感疫苗免疫原性:病毒微量中和与血凝抑制试验比较

A comparison of viral microneutralization and haemagglutination inhibition assays as measures of seasonal inactivated influenza vaccine immunogenicity in the first year after reduced intensity conditioning, lymphocyte depleted allogeneic haematopoietic stem cell transplant.
PubMed 文献 · Vaccine · 2018-12-13

该研究比较了病毒微量中和试验(VMN)与血凝抑制试验(HAI)在评估28例异基因造血干细胞移植(HSCT)受者接种三价2015-2016季节性灭活流感疫苗(SIIV)后第一年免疫应答中的表现。接种中位时间为移植后78.5天(范围24-363天)。结果显示移植后第一年对SIIV缺乏血清应答,提示该高危人群需新型免疫原性疫苗配方和接种方案。

要点

  • HSCT后第一年接种SIIV,HAI和VMN均显示血清应答率低。
  • VMN与HAI检测的几何均值滴度在甲型流感组分存在差异,但几何均值比相似。
  • 患者年龄、淋巴细胞计数、移植至接种时间、供者类型、GVHD或IST均与抗体滴度无相关性。

核心结论

  • 异基因HSCT后第一年接种季节性灭活流感疫苗血清应答率低,需新型疫苗配方和接种方案。

研究设计与样本

  • 研究纳入28例异基因HSCT受者,在移植后第一年接种三价2015-2016 SIIV,比较HAI与VMN检测的免疫应答。

主要发现

  • 基线及接种后HAI滴度≥1:40的比例:A(H1N1)pdm09为28.6%和25%,A(H3N2)两个时间点均为14.3%,B(Phuket)为32.1%和25%。
  • VMN检测的几何均值滴度(GMT)在A(H1N1)pdm09和A(H3N2)高于HAI,在B(Phuket)低于HAI(p<0.05)。
  • HAI与VMN检测的基线至接种后几何均值比(GMR)在所有组分相似(p>0.05)。
  • ELISA-VMN仅检测到1例对A(H1N1)的血清转换。
  • 患者年龄、淋巴细胞计数、移植至接种天数、供者类型、接种时GVHD或免疫抑制治疗(IST)与两种方法检测的基线或接种后滴度均无相关性。

临床怎么用

  • HSCT后第一年接种SIIV免疫原性低,应关注该高危人群的疫苗接种策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Traditionally, immune response to influenza vaccines has been measured using the haemagglutination inhibition (HAI) assay. A broader repertoire of techniques including the sensitive viral microneutralization (VMN) assay is now recommended by the European Medicines Agency (EMA). Comparing HAI and VMN, we determined immune response to a trivalent 2015-2016 seasonal inactivated influenza vaccine (SIIV) administered to 28 recipients of allogeneic haematopoietic stem cell transplant (HSCT). Vaccination was within the first-year post-transplant at a median of 78.5 (24-363) days. The proportion of patients with baseline and post-vaccination HAI titres ≥ 1:40 were 28.6% and 25% for A(H1N1)pdm09, 14.3% at both timepoints for A(H3N2), and 32.1% and 25% for B(Phuket). Pre and Post-vaccination geometric mean titres(GMT) were higher by VMN than HAI for A(H1N1)pdm09 and A(H3N2), but lower for B(Phuket)(p=<0.05). Geometric mean ratios(GMR) of baseline and post-vaccination titres were similar by HAI and VMN(p > 0.05) for all components. A single seroconversion to A(H1N1) was detected by ELISA-VMN. None of patient age, lymphocyte count, days from transplant to vaccination, donor type, or graft-versus-host disease (GVHD) or immunosuppressive therapy (IST) at vaccination correlated with baseline or post-vaccination titres by either assay. This absence of seroresponse to SIIV in the first-year post HSCT highlights the need for novel immunogenic vaccination formulations and schedules in this high-risk population.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Miller PDE, de Silva TI, Leonard H, et al. A comparison of viral microneutralization and haemagglutination inhibition assays as measures of seasonal inactivated influenza vaccine immunogenicity in the first year after reduced intensity conditioning, lymphocyte depleted allogeneic haematopoietic stem cell transplant. Vaccine. 2018. PMID: 30554797. doi:10.1016/j.vaccine.2018.11.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。